INCY vs. IDXX
INCY (Incyte Corporation) and IDXX (IDEXX Laboratories, Inc.) are both stocks. Both are in the Healthcare sector — INCY in Biotechnology, IDXX in Diagnostics & Research. Over the past 10 years, INCY returned 2.27%/yr vs 20.23%/yr for IDXX. At a 0.28 correlation, their price movements are largely independent.
Performance
INCY vs. IDXX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INCY achieves a 1.89% return, which is significantly higher than IDXX's -17.05% return. Over the past 10 years, INCY has underperformed IDXX with an annualized return of 2.27%, while IDXX has yielded a comparatively higher 20.23% annualized return.
INCY
- 1D
- -1.70%
- 1M
- 2.11%
- YTD
- 1.89%
- 6M
- 4.07%
- 1Y
- 46.34%
- 3Y*
- 18.14%
- 5Y*
- 3.15%
- 10Y*
- 2.27%
IDXX
- 1D
- -0.18%
- 1M
- 0.19%
- YTD
- -17.05%
- 6M
- -20.59%
- 1Y
- 6.91%
- 3Y*
- 7.57%
- 5Y*
- -0.19%
- 10Y*
- 20.23%
INCY vs. IDXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
INCY Incyte Corporation | 1.89% | 43.00% | 10.00% | -21.83% | 9.43% | -15.61% | -0.39% | 37.32% | -32.86% | -5.55% |
IDXX IDEXX Laboratories, Inc. | -17.05% | 63.63% | -25.51% | 36.06% | -38.04% | 31.73% | 91.43% | 40.38% | 18.95% | 33.35% |
Correlation
The correlation between INCY and IDXX is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Nov 4, 1993 | 0.28 |
Fundamentals
INCY:
$7.06
IDXX:
$18.08
INCY:
14.26
IDXX:
31.04
INCY:
0.01
IDXX:
2.68
INCY:
3.81
IDXX:
7.65
INCY:
$5.36B
IDXX:
$4.45B
INCY:
$3.76B
IDXX:
$2.76B
INCY:
$1.80B
IDXX:
$1.52B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INCY vs. IDXX — Risk / Return Rank
INCY
IDXX
INCY vs. IDXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Incyte Corporation (INCY) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INCY | IDXX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.24 | ||
| Sortino ratioReturn per unit of downside risk | +1.45 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.09 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 2.54 | 0.22 | +2.32 |
| Martin ratioReturn relative to average drawdown | 5.67 | 0.46 | +5.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| INCY | IDXX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.41 | 0.17 | +1.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.11 | -0.01 | +0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.07 | 0.62 | -0.55 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.51 | -0.30 |
Drawdowns
INCY vs. IDXX - Drawdown Comparison
The maximum INCY drawdown since its inception was -98.54%, which is greater than IDXX's maximum drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for INCY and IDXX.
Loading charts...
Drawdown Indicators
| INCY | IDXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.54% | -81.42% | -17.12% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -31.04% | +12.71% |
Max Drawdown (3Y)Largest decline over 3 years | -33.83% | -37.41% | +3.58% |
Max Drawdown (5Y)Largest decline over 5 years | -41.53% | -54.00% | +12.47% |
Max Drawdown (10Y)Largest decline over 10 years | -66.47% | -54.00% | -12.47% |
Current DrawdownCurrent decline from peak | -34.08% | -26.81% | -7.27% |
Average DrawdownAverage peak-to-trough decline | -59.91% | -21.00% | -38.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.19% | 15.03% | -6.84% |
Volatility
INCY vs. IDXX - Volatility Comparison
Incyte Corporation (INCY) has a higher volatility of 9.23% compared to IDEXX Laboratories, Inc. (IDXX) at 8.57%. This indicates that INCY's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INCY | IDXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.23% | 8.57% | +0.66% |
Volatility (6M)Calculated over the trailing 6-month period | 23.30% | 19.89% | +3.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.04% | 41.46% | -8.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.41% | 35.28% | -5.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.28% | 33.01% | +1.27% |
Dividends
INCY vs. IDXX - Dividend Comparison
Neither INCY nor IDXX has paid dividends to shareholders.
Financials
INCY vs. IDXX - Financials Comparison
This section allows you to compare key financial metrics between Incyte Corporation and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INCY vs. IDXX - Profitability Comparison
INCY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a gross profit of 0.00 and revenue of 1.27B. Therefore, the gross margin over that period was 0.0%.
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
INCY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported an operating income of 301.12M and revenue of 1.27B, resulting in an operating margin of 23.7%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
INCY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a net income of 303.33M and revenue of 1.27B, resulting in a net margin of 23.8%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
Frequently Asked Questions
INCY and IDXX have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INCY has higher volatility (9.23%) compared to IDXX (8.57%). In terms of maximum drawdown, INCY dropped -98.54% vs IDXX's -81.42%.
INCY currently has the higher Sharpe Ratio (1.41 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INCY and IDXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer